Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Opioids
HHS OIG Report Finds Opioid Use Decreasing on Medicare Part D
Earlier this year, the Department of Health and Human Services Office of Inspector General (HHS-OIG) completed a report in which…
White House Office of National Drug Control Policy (ONDCP) Releases Opioid…
The White House Office of National Drug Control Policy (“ONDCP”) recently released a publication outlining strategies intended to…
NY State Overbilled Medicaid Almost $40 Million for Opioid Treatment…
The Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) recently released the results of an audit…
EHR Vendor Involved in Opioid Kickback Scheme
On Monday, January 27, 2020, Practice Fusion, Inc. admitted to participating in a kickback scheme aimed at increasing opioid…
Oklahoma and Endo Enter into Settlement Over Opioid Crisis
Oklahoma Attorney General Mike Hunter recently announced an $8.75 million settlement with Endo Pharmaceuticals, Inc. for the…
API Manufacturers Beware – New Washington Opioid Lawsuit Targets…
By Dr. Seth B. Whitelaw
As predicted, the epidemic of opioid-related lawsuits continues to pick-up steam with the State of…
FDA Did Not Verify Whether Opioid-Curbing Effort Worked
According to a study recently published in JAMA Internal Medicine, the Food and Drug Administration (FDA) did not verify whether a…
New York Insurance Regulator to Bring Enforcement Action Against Opioid…
New York’s insurance regulator, the New York Department of Financial Services (“NYDFS”), recently issued a letter of intent to…
HHS Releases New Guidance on Opioid Tapering
Recently, the United States Department of Health and Human Services (HHS) issued new guidance on appropriate tapering or…
OIG Report Concludes that DEA was Slow to Respond to Opioid Diversion…
Recently, the Justice Department Office of Inspector General (“OIG”) released a report criticizing the regulatory activities and…